Table 1.

Demographic characteristics of the study group (N = 106)

CharacteristicsPSA recurrence*P
NoYes
Age at diagnosis (y)0.3659
    Mean ± SD57.9 ± 8.460.0 ± 7.6
    Median (range)57.8 (40.6-71.8)61.6 (40.1-73.2)
Follow-up after RP (mo)0.0036
    Mean ± SD43.8 ± 31.665.1 ± 25.9
    Median (range)35.1 (2.7-111.9)67.7 (6.1-118.0)
PSA at diagnosis (ng/mL)0.0135
    Mean ± SD7.0 ± 6.910.3 ± 6.9
    Median (range)5.4 (2.7-118.0)8.3 (2.9-28.0)
Dichotomized age at diagnosis (y)0.2021
    <5018 (85.7%)3 (14.3%)
    ≥5057 (75.2%)22 (27.8%)
Pathologic stage0.0002
    pT254 (88.5%)7 (11.5%)
    pT3-420 (55.6%)16 (44.4%)
Pathologic GS0.0002
    2-650 (92.6%)4 (7.4%)
    717 (54.8%)14 (45.2%)
    8-108 (61.5%)5 (38.5%)

Abbreviations: GS, Gleason score; PSA, prostate-specific antigen; RP, radical prostatectomy.

  • *Defined as at least one value >0.2 ng/mL.